Use of glucagon-like polypeptide 2 analogs for intestinal failure.

导出 LinkOut

翻译打印收藏纠错

作者： Monique L,Goldschmidt ^[1] ; Stephanie,Oliveira ^[1] ; Crystal,Slaughter ^[1] ; Samuel A,Kocoshis ^[1]

作者单位： Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of Cincinnati College of Medicine, Cincinnati, OH, USA.;Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. ^[1]

关键词 Short bowel syndrome apraglutide glepaglutide glucagon-like polypeptide-2 intestinal failure malabsorption small bowel adaptation teduglutide

主题词胰高血糖素样肽2(Glucagon-Like Peptide 2);人类(Humans);动物(Animals);短肠综合征(Short Bowel Syndrome);半衰期(Half-Life);胰高血糖素样肽1(Glucagon-Like Peptide 1);胃肠病用药(Gastrointestinal Agents);小肠(Intestine, Small);胃肠活动(Gastrointestinal Motility);成年人(Adult)

DOI 10.1080/14656566.2024.2431291

PMID 39588923

发布时间 2024-12-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on pharmacotherapy

2024年25卷18期

2341-2346页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Use of glucagon-like polypeptide 2 analogs for intestinal failure.

Expert opinion on pharmacotherapy

相似文献

Expert opinion on pharmacotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Use of glucagon-like polypeptide 2 analogs for intestinal failure.

Expert opinion on pharmacotherapy

相似文献

Expert opinion on pharmacotherapy

相关期刊

检索历史清除